Tiret L., Rigat B., Visvikis S., et al. Evidence from combined segregation and lincage analysis, that a variant of the angiotensin-converting enzyme ACE gene controls plasma levels. Amer. J. Hum. Genet. 1992; 51:197-205.

7. Josep Redon; Felipe Javier Chaves; Youlian Liao; Jose Maria Pascual; Eduardo Rovira; Maria Eugenia Armengod; Richard S. Cooper. Influence of the I/D Polymorphism of the Angiotensin-Converting Enzyme Gene on the Outcome of Microalbuminuria in Essential Hypertension. Hypertension. 2000 Jan; 35(1 Pt 2):

490-495.

8. Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events. The New England Journal of Medicine. 2008; №. 10(15), V.

358: 1547-1559.

9. Мухин Н.А. Хронические прогрессирующие заболевания почек и современная нефропротективная стратегия - обоснование, возможности и перспективы. Центрально-Азиатский медицин­

374

Терапевтический вестник

ский журнал. 2004; X(5): 14-20.

10. Ruggenenti P., Perna A., Zoccali C. et al. Chronic proteinuric nephropathies. Outcomes and response to treatment in a prospective cohort of 352 patients: differences between women and men in relation to the ACE gene polymorphism. Gruppo Italiano di Studi Epidemologici in Nefrologia (Gisen). J. Am. Soc. Nephrol. 2000; V. 11(1): 88-96.

11. Zitta S., Stoschitzky K., Zweiker R. et al. Dynamic renal function testing by compartmental analysis: assessment of renal functional reserve in essential hypertension. Nephrol. Dial. Transplant. 2000; V.(15): 1162-1169.

12. Ничик Т.Е., Каюков И.Г., Есаян А.М

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69